Lissun Raises ₹48 Crore in Series A Funding Led by Colossa Ventures

BestVantage Investments portfolio company Lissun has raised ₹48 crore in Series A funding, marking a major milestone for the Gurugram-based HealthTech company focused on children with special needs and developmental delays.

Lissun Raises ₹48 Crore in Series A Funding Led by Colossa Ventures

The round was led by Colossa Ventures, with participation from existing investors including RPSG Capital Ventures, IvyCap Ventures, Rainmatter, Multiply Ventures and SucSEED Ventures, alongside new investors Physis Capital, New Age India Fund and Beyond Capital Ventures.

Founded in 2021 by Krishna Veer Singh and Tarun Gupta, Lissun operates through Sunshine by LISSUN, a child development network combining clinical care, therapy and technology. The company currently operates 25 centres, delivers more than 10,000 therapy sessions every month, and has grown 4X over the past year.

The new capital will support Lissun's next phase of expansion. The company plans to grow its Sunshine by LISSUN centres across key Indian cities, strengthen clinical processes and build AI-led solutions using its proprietary technology and data.

Technology is central to Lissun's larger ambition. While its existing AI tools support therapists and parents, the company aims to develop a broader AI-led child development platform capable of reaching millions of children and families who lack access to quality developmental care.

The latest round also reflects continued investor confidence in Lissun's growth trajectory. RPSG Capital Ventures, an existing investor, has participated again, while Colossa Ventures leads the company's Series A.

Lissun had previously raised $2.5 million in a 2024 pre-Series A round led by RPSG Capital Ventures and secured additional capital in 2026.

For BestVantage Investments, this Series A represents an important milestone for one of its portfolio companies. Lissun's combination of physical child development centres, clinical expertise, proprietary data and AI-led technology places it at an interesting intersection of HealthTech, child development and scalable digital healthcare.

With ₹48 crore of fresh capital, Lissun is now entering its next phase: expanding its physical footprint while building technology that could extend its reach far beyond its centres.

The next chapter for Lissun is about taking quality developmental care from a network of centres to a technology-enabled platform with the potential to serve millions.